Document Detail

Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control.
MedLine Citation:
PMID:  19461649     Owner:  NLM     Status:  MEDLINE    
Hypertensive patients with obstructive sleep apnea syndrome (OSAS) constitute a high-risk group for metabolic syndrome. OSAS directly induces negative intrathoracic pressure and decreases pulmonary stretch receptor stimulation, chemoreceptor stimulation, hypoxemia, hypercapnia and microarousal. These changes potentiate various risk factors, including the sympathetic nervous system, renin-angiotensin-aldosterone system and inflammation. Early detection and treatment of OSAS in asymptomatic hypertensive patients is essentially important to prevent hypertensive target organ damage and subsequent cardiovascular events. Continuous positive airway pressure (CPAP) therapy, a first-line treatment in hypertensive patients with moderate to severe OSAS, reduces ambulatory BP level, particularly during the sleep period, and midnight BP surge. However, individual differences in the BP-lowering effect of CPAP have been observed. OSAS hypertensive patients who do not tolerate CPAP remain at a high risk for cardiovascular disease because of negative intrathoracic pressure and need more aggressive antihypertensive treatment to achieve 24-h BP control with nocturnal BP <120/70 mm Hg.
Kazuomi Kario
Related Documents :
18091749 - Blood pressure variability causes spurious identification of hypertension in clinical s...
15711679 - The effect of combination therapy on regression of left ventricular hypertrophy in case...
8642189 - Prostacyclin biosynthesis in essential hypertension before and during treatment.
11281229 - Blood pressure and arterial compliance in young adults: the minnesota children's blood ...
8203769 - Circulatory and plasma catecholamine responses to mental stress in young subjects with ...
15839719 - Hypertension in the elderly: a japanese perspective.
16325189 - Linear voltage profiles and flow homogeneity in pressurized planar electrochromatography.
17600159 - Effect of hypobaric air, oxygen, heliox (50:50), or heliox (80:20) breathing on air bub...
24202689 - Cardiac activity, ventilation rate and acid-base regulation in rainbow trout exposed to...
Publication Detail:
Type:  Journal Article; Review     Date:  2009-05-22
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  32     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-06     Completed Date:  2009-12-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  537-41     Citation Subset:  IM    
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Yakushiji, Shimotsuke, Tochigi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / therapeutic use
Blood Pressure / physiology*
Continuous Positive Airway Pressure
Hypertension / drug therapy*,  etiology,  physiopathology*,  therapy
Sleep Apnea, Obstructive / complications,  physiopathology*,  therapy
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT(1) receptor axis vs. ACE2-ang...
Next Document:  Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling ...